Chevy Chase Trust’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $23.2M | Sell |
290,167
-10,284
| -3% | -$848K | 0.07% | 243 |
|
|
2025
Q4 | $25.6M | Sell |
300,451
-4,390
| -1% | -$360K | 0.07% | 225 |
|
|
2025
Q3 | $23.7M | Sell |
304,841
-10,226
| -3% | -$799K | 0.07% | 240 |
|
|
2025
Q2 | $24.6M | Sell |
315,067
-1,028
| -0.3% | -$76.7K | 0.07% | 231 |
|
|
2025
Q1 | $22.9M | Sell |
316,095
-826
| -0.3% | -$59.1K | 0.07% | 233 |
|
|
2024
Q4 | $23.5M | Sell |
316,921
-13,472
| -4% | -$943K | 0.07% | 225 |
|
|
2024
Q3 | $21.8M | Sell |
330,393
-3,462
| -1% | -$252K | 0.07% | 252 |
|
|
2024
Q2 | $30.8M | Sell |
333,855
-8,839
| -3% | -$783K | 0.1% | 181 |
|
|
2024
Q1 | $32.7M | Sell |
342,694
-2,959
| -0.9% | -$249K | 0.11% | 177 |
|
|
2023
Q4 | $26.4M | Sell |
345,653
-2,380
| -0.7% | -$166K | 0.09% | 195 |
|
|
2023
Q3 | $24.1M | Sell |
348,033
-7,117
| -2% | -$572K | 0.1% | 190 |
|
|
2023
Q2 | $33.5M | Sell |
355,150
-10,538
| -3% | -$916K | 0.13% | 154 |
|
|
2023
Q1 | $30.3M | Buy |
365,688
+3,417
| +0.9% | +$269K | 0.12% | 157 |
|
|
2022
Q4 | $27M | Sell |
362,271
-22,935
| -6% | -$1.77M | 0.11% | 176 |
|
|
2022
Q3 | $31.8M | Buy |
385,206
+2,035
| +0.5% | +$196K | 0.14% | 149 |
|
|
2022
Q2 | $36.4M | Buy |
383,171
+334
| +0.1% | +$34.6K | 0.15% | 140 |
|
|
2022
Q1 | $45.1M | Buy |
382,837
+963
| +0.3% | +$108K | 0.16% | 135 |
|
|
2021
Q4 | $49.5M | Sell |
381,874
-9,212
| -2% | -$1.07M | 0.16% | 131 |
|
|
2021
Q3 | $44.3M | Sell |
391,086
-13,398
| -3% | -$1.53M | 0.15% | 138 |
|
|
2021
Q2 | $41.9M | Sell |
404,484
-22,943
| -5% | -$2.16M | 0.14% | 147 |
|
|
2021
Q1 | $35.8M | Sell |
427,427
-35,174
| -8% | -$2.97M | 0.13% | 163 |
|
|
2020
Q4 | $42.2M | Sell |
462,601
-9,295
| -2% | -$771K | 0.15% | 152 |
|
|
2020
Q3 | $37.7M | Sell |
471,896
-37,802
| -7% | -$2.95M | 0.15% | 146 |
|
|
2020
Q2 | $35.2M | Sell |
509,698
-33,119
| -6% | -$2.35M | 0.14% | 156 |
|
|
2020
Q1 | $34.1M | Buy |
542,817
+8,925
| +2% | +$644K | 0.16% | 142 |
|
|
2019
Q4 | $41.5M | Buy |
533,892
+2,832
| +0.5% | +$221K | 0.16% | 143 |
|
|
2019
Q3 | $38.9M | Sell |
531,060
-1,131
| -0.2% | -$79.4K | 0.16% | 145 |
|
|
2019
Q2 | $32.8M | Buy |
532,191
+1,635
| +0.3% | +$98.9K | 0.14% | 169 |
|
|
2019
Q1 | $31.2M | Buy |
530,556
+3,156
| +0.6% | +$180K | 0.13% | 174 |
|
|
2018
Q4 | $26.9M | Sell |
527,400
-4,152
| -0.8% | -$210K | 0.13% | 170 |
|
|
2018
Q3 | $30.8M | Sell |
531,552
-16,839
| -3% | -$824K | 0.13% | 176 |
|
|
2018
Q2 | $26.6M | Sell |
548,391
-348
| -0.1% | -$16.2K | 0.12% | 203 |
|
|
2018
Q1 | $25.5M | Sell |
548,739
-20,055
| -4% | -$871K | 0.11% | 203 |
|
|
2017
Q4 | $21.4M | Sell |
568,794
-573
| -0.1% | -$21K | 0.09% | 247 |
|
|
2017
Q3 | $20.7M | Buy |
569,367
+13,128
| +2% | +$501K | 0.09% | 247 |
|
|
2017
Q2 | $21.9M | Sell |
556,239
-5,679
| -1% | -$207K | 0.1% | 225 |
|
|
2017
Q1 | $17.6M | Buy |
561,918
+16,986
| +3% | +$532K | 0.09% | 262 |
|
|
2016
Q4 | $17M | Buy |
544,932
+7,110
| +1% | +$230K | 0.09% | 254 |
|
|
2016
Q3 | $21.6M | Sell |
537,822
-7,149
| -1% | -$269K | 0.12% | 202 |
|
|
2016
Q2 | $18.1M | Sell |
544,971
-522
| -0.1% | -$17.9K | 0.1% | 232 |
|
|
2016
Q1 | $16M | Buy |
545,493
+9,567
| +2% | +$264K | 0.09% | 258 |
|
|
2015
Q4 | $14.1M | Buy |
535,926
+4,992
| +0.9% | +$130K | 0.08% | 274 |
|
|
2015
Q3 | $12.6M | Buy |
530,934
+18,738
| +4% | +$452K | 0.08% | 289 |
|
|
2015
Q2 | $12.2M | Buy |
512,196
+5,220
| +1% | +$118K | 0.07% | 304 |
|
|
2015
Q1 | $12M | Buy |
506,976
+21,462
| +4% | +$481K | 0.07% | 306 |
|
|
2014
Q4 | $10.3M | Buy |
485,514
+738
| +0.2% | +$14.8K | 0.06% | 334 |
|
|
2014
Q3 | $8.25M | Buy |
484,776
+31,632
| +7% | +$499K | 0.05% | 370 |
|
|
2014
Q2 | $6.48M | Sell |
453,144
-6,720
| -1% | -$91.1K | 0.05% | 414 |
|
|
2014
Q1 | $5.68M | Sell |
459,864
-20,538
| -4% | -$237K | 0.04% | 437 |
|
|
2013
Q4 | $5.26M | Buy |
480,402
+6,642
| +1% | +$74.9K | 0.04% | 449 |
|
|
2013
Q3 | $5.5M | Buy |
473,760
+8,592
| +2% | +$101K | 0.04% | 419 |
|
|
2013
Q2 | $5.21M | Buy |
+465,168
| New | +$5.51M | 0.05% | 402 |
|
Other funds holding EW
VCM
VPM
Chevy Chase Trust's EW Position: Q1 2026 in Review
Chevy Chase Trust reduced its Edwards Lifesciences (EW) stake by 3.4% in Q1 2026, selling an estimated $848K and leaving 290,167 shares worth $23.2M. The position accounts for 0.07% of the portfolio, ranked #243.
Chevy Chase Trust first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $49.5M in Q4 2021. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Chevy Chase Trust held 290,167 shares of Edwards Lifesciences worth $23.2M as of Q1 2026.
- Chevy Chase Trust sold 10,284 Edwards Lifesciences shares in Q1 2026, an estimated $848K.
- Edwards Lifesciences made up 0.07% of Chevy Chase Trust's portfolio in Q1 2026, its #243 holding.
- Chevy Chase Trust first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
- Chevy Chase Trust's Edwards Lifesciences position peaked at $49.5M in Q4 2021.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Chevy Chase Trust's 13F filing for Q1 2026, filed 15 May 2026.